Cardio Diagnostics Inc. (CDIO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.60
0.03 (5.15%)
At close: Jan 15, 2025, 10:55 AM
Company Description
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test.
Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Cardio Diagnostics Inc.
Country | United States |
IPO Date | Jan 14, 2022 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 7 |
CEO | Dr. Meeshanthini V. Dogan Ph.D. |
Contact Details
Address: 400 N Aberdeen St Chicago, Illinois United States | |
Website | https://cardiodiagnosticsinc.com |
Stock Details
Ticker Symbol | CDIO |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001870144 |
CUSIP Number | 14159C103 |
ISIN Number | US14159C1036 |
Employer ID | 87-0925574 |
SIC Code | 2835 |
Key Executives
Name | Position |
---|---|
Dr. Meeshanthini V. Dogan Ph.D. | Co-Founder, Chief Executive Officer & Director |
Elisa Michael Luqman Esq., J.D., M.B.A. | Chief Financial Officer |
Timur Dogan Ph.D. | Chief Technology Officer |
Dr. Robert A. Philibert M.D., Ph.D. | Co-Founder, Chief Medical Officer & Director |
Khullani Abdullahi J.D. | Vice President of Revenue & Strategy |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 04, 2024 | 8-K | Current Report |
Dec 03, 2024 | 424B3 | Filing |
Nov 22, 2024 | S-1 | Filing |
Nov 18, 2024 | 8-K | Current Report |
Nov 13, 2024 | 10-Q | Quarterly Report |
Oct 10, 2024 | 4 | Filing |
Oct 10, 2024 | 4 | Filing |
Oct 10, 2024 | 4 | Filing |
Oct 10, 2024 | 4 | Filing |
Oct 09, 2024 | 4/A | [Amend] Filing |